Eyes On Eyecare

Sydnexis, Inc. has?received FDA acceptance?for its new drug application (NDA) of SYD-101, a proprietary formulation under clinical development for the treatment of pediatric myopia progression. Learn more on Glance: https://lnkd.in/eC95J9jD #GlanceNews Patrick Johnson

ZEISS Professional Education partnered with Eyes On Eyecare for the 5th Ophthalmic Medical Education Summit in August 2024. Discover what Dr. John Doane, MD, FACS, Sidney Gicheru, MD, and Bruce Rivers, MD, had to say about SMILE with the ZEISS VISUMAX 800, including case studies on efficiency, outcomes, and recovery. https://hubs.ly/Q039PC6H0 #eyecare?

The Foundation Fighting Blindness (FFB) has officially?named Amy Laster, PhD, as the organization's new chief scientific officer (CSO)—6 months following the start of her tenure as interim CSO. Learn more on Glance: https://lnkd.in/e2ezsTjV #eyecarenews #FoundationFightingBlindness?

Neurotech Pharmaceuticals, Inc.?announced the FDA has approved?its allogeneic encapsulated cell-based gene therapy for the treatment of macular telangiectasia type 2 (MacTel): ENCELTO (revakinagenetaroretcel-lwey). Important to note:?This marks a historic moment, as ENCELTO is now the?first-ever FDA-approved treatment?for this neurodegenerative retinal disease. Learn more on Glance: https://lnkd.in/egb5dA9f #GlanceNews #eyecare Rich Small

In the latest episode of Glaucoma Pressure Points, Justin Schweitzer, OD, FAAO, and Walter Whitley, OD, MBA, FAAO, break down a challenging case: a glaucoma patient with controlled IOP and ongoing visual field loss. How do ocular surface disease and adherence factor into treatment choices? See what they have to say here: https://hubs.ly/Q039Prtg0

Just months after offering a?sneak peek?of its new METIS ophthalmic microscope system, Haag-Streit USA officially?announced the U.S. launch?of the METIS 900 this week. Learn more on Glance: https://lnkd.in/egrV-_QF #GlanceNews #eyecare Michelle Baxter

Expand your expertise in corneal health with sessions on cutting-edge diagnostics and the latest therapeutic updates. Earn up to 2.5 free COPE-accredited CE credits virtually at the Corneal Health Summit on April 12. Register now: https://hubs.ly/Q039hZhK0? #eyecare #virtualevent

See how a low-dose pilocarpine, preservative-free eye drop could change the way you treat presbyopia! Join Jackie Garlich, O.D., F.A.A.O., and other experts for an interactive one-hour virtual conversation. Here’s what’s on the agenda: ? How it works and why it’s unique ? Tips for improving patient comfort and education ? Insights on tolerability and efficacy ? Strategies for selecting the right patients Bring your questions and join the conversation with top KOLs. Register here: https://hubs.ly/Q0392_v-0 #eyecare Prescribing Information: https://hubs.ly/Q0392zqg0

Opus Genetics, Inc. announced?two clinical program updates and a new regulatory designation status?for its phentolamine ophthalmic solution (POS) 0.75%. The formulation is currently under clinical investigation for the treatment of visual loss (decreased visual acuity [VA]) in low light conditions (DLD) associated with keratorefractive surgery. Learn more on Glance: https://lnkd.in/ed3ncsbA #GlanceNews #eyecare Ben Yerxa

Are you struggling with recurrent corneal erosions in your patients? Get a cheat sheet that covers everything you need to know to break the cycle. Discover personalized treatment strategies, get guidance on making an accurate diagnosis, and more. Learn more and download the cheat sheet: https://hubs.ly/Q038FkRq0 #cornealerosions